ICD-10-CM Alphabetic Index to Diseases and Injuries

Disorder (of)

Follow the subterms below to reach a more specific code.

— see also Disease

acantholytic L11.9
specified NEC L11.8
acute
psychotic — see Psychosis, acute
stress F43.0
adjustment (grief) F43.20
with
anxiety F43.22
with depressed mood F43.23
conduct disturbance F43.24
with emotional disturbance F43.25
depressed mood F43.21
with anxiety F43.23
other specified symptom F43.29
adrenal (capsule) (gland) (medullary) E27.9
specified NEC E27.8
adrenogenital E25.9 — see also Adrenogenital syndrome
drug-induced E25.8
iatrogenic E25.8
idiopathic E25.8
adult personality (and behavior) F69
specified NEC F68.8
affective (mood) — see Disorder, mood
aggressive, unsocialized F91.1
alcohol-related F10.99
with
amnestic disorder, persisting F10.96
anxiety disorder F10.980
dementia, persisting F10.97
intoxication F10.929
with delirium F10.921
uncomplicated F10.920
mood disorder F10.94
other specified F10.988
psychotic disorder F10.959
with
delusions F10.950
hallucinations F10.951
sexual dysfunction F10.981
sleep disorder F10.982
alcohol use
mild F10.10
with
alcohol-induced
anxiety disorder F10.180
bipolar and related disorder F10.14
depressive disorder F10.14
psychotic disorder F10.159
sexual dysfunction F10.181
sleep disorder F10.182
alcohol intoxication F10.129
delirium F10.121
in remission (early) (sustained) F10.11
moderate or severe F10.20
with
alcohol-induced
anxiety disorder F10.280
bipolar and related disorder F10.24
depressive disorder F10.24
major neurocognitive disorder, amnestic-confabulatory type F10.26
major neurocognitive disorder, nonamnestic-confabulatory type F10.27
mild neurocognitive disorder F10.288
psychotic disorder F10.259
sexual dysfunction F10.281
sleep disorder F10.282
alcohol intoxication F10.229
delirium F10.221
in remission (early) (sustained) F10.21
allergic — see Allergy
alveolar NEC J84.09
amino-acid
cystathioninuria E72.19
cystinosis E72.04
cystinuria E72.01
glycinuria E72.09
homocystinuria E72.11
metabolism — see Disturbance, metabolism, amino-acid
specified NEC E72.89
neonatal, transitory P74.8
renal transport NEC E72.09
transport NEC E72.09
amnesic, amnestic
alcohol-induced F10.96
with dependence F10.26
due to (secondary to) general medical condition F04
psychoactive NEC-induced F19.96
with
abuse F19.16
dependence F19.26
sedative, hypnotic or anxiolytic-induced F13.96
with dependence F13.26
amphetamine-type substance use
mild F15.10
in remission (early) (sustained) F15.11
moderate F15.20
in remission (early) (sustained) F15.21
severe F15.20
in remission (early) (sustained) F15.21
amphetamine (or other stimulant) use
mild
with
amphetamine (or other stimulant)-induced
anxiety disorder F15.180
bipolar and related disorder F15.14
depressive disorder F15.14
obsessive-compulsive and related disorder F15.188
psychotic disorder F15.159
sexual dysfunction F15.181
amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbances F15.122
without perceptual disturbances F15.129
intoxication delirium F15.121
moderate or severe
with
amphetamine (or other stimulant)-induced
anxiety disorder F15.280
obsessive-compulsive and related disorder F15.288
sexual dysfunction F15.281
bipolar and related disorder F15.24
depressive disorder F15.24
psychotic disorder F15.259
amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbances F15.222
without perceptual disturbances F15.229
intoxication delirium F15.221
anaerobic glycolysis with anemia D55.29
anxiety F41.9
due to (secondary to)
alcohol F10.980
in
abuse F10.180
dependence F10.280
amphetamine F15.980
in
abuse F15.180
dependence F15.280
anxiolytic F13.980
in
abuse F13.180
dependence F13.280
caffeine F15.980
in
abuse F15.180
dependence F15.280
cannabis F12.980
in
abuse F12.180
dependence F12.280
cocaine F14.980
in
abuse F14.180
dependence F14.180
general medical condition F06.4
hallucinogen F16.980
in
abuse F16.180
dependence F16.280
hypnotic F13.980
in
abuse F13.180
dependence F13.280
inhalant F18.980
in
abuse F18.180
dependence F18.280
phencyclidine F16.980
in
abuse F16.180
dependence F16.280
psychoactive substance NEC F19.980
in
abuse F19.180
dependence F19.280
sedative F13.980
in
abuse F13.180
dependence F13.280
volatile solvents F18.980
in
abuse F18.180
dependence F18.280
generalized F41.1
illness F45.21
mixed
with depression (mild) F41.8
specified NEC F41.3
organic F06.4
phobic F40.9
of childhood F40.8
specified NEC F41.8
aortic valve — see Endocarditis, aortic
aromatic amino-acid metabolism E70.9
specified NEC E70.89
arteriole NEC I77.89
artery NEC I77.89
articulation — see Disorder, joint
attachment (childhood)
disinhibited F94.2
reactive F94.1
attention-deficit hyperactivity (adolescent) (adult) (child) F90.9
combined
presentation F90.2
type F90.2
hyperactive
impulsive presentation F90.1
type F90.1
inattentive
presentation F90.0
type F90.0
specified type NEC F90.8
attention-deficit without hyperactivity (adolescent) (adult) (child) F98.8
auditory processing (central) H93.25
autistic F84.0
autism spectrum F84.0
autoimmune D89.89
autonomic nervous system G90.9
specified NEC G90.89
avoidant
child or adolescent F40.10
restrictive food intake F50.82
balance
acid-base E87.8
mixed E87.4
electrolyte E87.8
fluid NEC E87.8
behavioral (disruptive) — see Disorder, conduct
bereavement, persistent complex F43.81
beta-amino-acid metabolism E72.89
bile acid and cholesterol metabolism E78.70
Barth syndrome E78.71
other specified E78.79
Smith-Lemli-Opitz syndrome E78.72
bilirubin excretion E80.6
binge eating F50.81-
binocular
movement H51.9
convergence
excess H51.12
insufficiency H51.11
internuclear ophthalmoplegia — see Ophthalmoplegia, internuclear
palsy of conjugate gaze H51.0
specified type NEC H51.8
vision NEC — see Disorder, vision, binocular
bipolar (I) (seasonal) (type 1) F31.9
and related due to a known physiological condition
with
manic features F06.33
manic- or hypomanic-like episodes F06.33
mixed features F06.34
current (or most recent) episode
depressed F31.9
with psychotic features F31.5
without psychotic features F31.30
mild F31.31
moderate F31.32
severe (without psychotic features) F31.4
with psychotic features F31.5
hypomanic F31.0
manic F31.9
with psychotic features F31.2
without psychotic features F31.10
mild F31.11
moderate F31.12
severe (without psychotic features) F31.13
with psychotic features F31.2
mixed F31.60
mild F31.61
moderate F31.62
severe (without psychotic features) F31.63
with psychotic features F31.64
severe depression (without psychotic features) F31.4
with psychotic features F31.5
in remission (currently) F31.70
in full remission
most recent episode
depressed F31.76
hypomanic F31.72
manic F31.74
mixed F31.78
in partial remission
most recent episode
depressed F31.75
hypomanic F31.71
manic F31.73
mixed F31.77
II (type 2) F31.81
organic F06.30
single manic episode F30.9
mild F30.11
moderate F30.12
severe (without psychotic symptoms) F30.13
with psychotic symptoms F30.2
specified NEC F31.89
bladder N32.9
functional NEC N31.9
in schistosomiasis B65.0
specified NEC N32.89
bleeding D68.9
blood D75.9
in congenital early syphilis A50.09
body dysmorphic F45.22
bone M89.9
continuity M84.9
specified type NEC M84.80
ankle M84.87-
fibula M84.86-
foot M84.87-
hand M84.84-
humerus M84.82-
neck M84.88
pelvis M84.859
radius M84.83-
rib M84.88
shoulder M84.81-
skull M84.88
thigh M84.85-
tibia M84.86-
ulna M84.83-
vertebra M84.88
density and structure M85.9
cyst — see also Cyst, bone, specified type NEC
aneurysmal — see Cyst, bone, aneurysmal
solitary — see Cyst, bone, solitary
diffuse idiopathic skeletal hyperostosis — see Hyperostosis, ankylosing
fibrous dysplasia (monostotic) — see Dysplasia, fibrous, bone
fluorosis — see Fluorosis, skeletal
hyperostosis of skull M85.2
osteitis condensans — see Osteitis, condensans
specified type NEC M85.8-
ankle M85.87-
foot M85.87-
forearm M85.83-
hand M85.84-
lower leg M85.86-
multiple sites M85.89
neck M85.88
rib M85.88
shoulder M85.81-
skull M85.88
thigh M85.85-
upper arm M85.82-
vertebra M85.88
development and growth NEC M89.20
carpus M89.24-
clavicle M89.21-
femur M89.25-
fibula M89.26-
finger M89.24-
humerus M89.22-
ilium M89.28
ischium M89.28
metacarpus M89.24-
metatarsus M89.27-
multiple sites M89.29
neck M89.28
radius M89.23-
rib M89.28
scapula M89.21-
skull M89.28
tarsus M89.27-
tibia M89.26-
toe M89.27-
ulna M89.23-
vertebra M89.28
specified type NEC M89.8X-
brachial plexus G54.0
branched-chain amino-acid metabolism E71.2
specified NEC E71.19
breast N64.9
agalactia — see Agalactia
associated with
lactation O92.70
specified NEC O92.79
pregnancy O92.20
specified NEC O92.29
puerperium O92.20
specified NEC O92.29
cracked nipple — see Cracked nipple
galactorrhea — see Galactorrhea
hypogalactia O92.4
lactation disorder NEC O92.79
mastitis — see Mastitis
nipple infection — see Infection, nipple
retracted nipple — see Retraction, nipple
specified type NEC N64.89
Briquet's F45.0
bullous, in diseases classified elsewhere L14
caffeine use
mild
with
caffeine-induced
anxiety disorder F15.180
sleep disorder F15.182
moderate or severe
with
caffeine-induced
anxiety disorder F15.280
sleep disorder F15.282
cannabis use
mild F12.10
with
cannabis-induced
anxiety disorder F12.180
psychotic disorder F12.159
sleep disorder F12.188
cannabis intoxication delirium F12.121
with perceptual disturbances F12.122
without perceptual disturbances F12.129
in remission (early) (sustained) F12.11
moderate or severe F12.20
with
cannabis-induced
anxiety disorder F12.280
psychotic disorder F12.259
sleep disorder F12.288
cannabis intoxication
with perceptual disturbances F12.222
without perceptual disturbances F12.229
delirium F12.221
in remission (early) (sustained) F12.21
carbohydrate
absorption, intestinal NEC E74.39
metabolism (congenital) E74.9
specified NEC E74.89
cardiac, functional I51.89
carnitine metabolism E71.40
cartilage M94.9
articular NEC — see Derangement, joint, articular cartilage
chondrocalcinosis — see Chondrocalcinosis
specified type NEC M94.8X-
articular — see Derangement, joint, articular cartilage
multiple sites M94.8X0
catatonia (due to known physiological condition) (with another mental disorder) F06.1
catatonic NOS F06.1
due to (secondary to) known physiological condition F06.1
organic NOS F06.1
central auditory processing H93.25
cervical
region NEC M53.82
root (nerve) NEC G54.2
character NOS F60.9
childhood disintegrative NEC F84.3
cholesterol and bile acid metabolism E78.70
Barth syndrome E78.71
other specified E78.79
Smith-Lemli-Opitz syndrome E78.72
choroid H31.9
atrophy — see Atrophy, choroid
degeneration — see Degeneration, choroid
detachment — see Detachment, choroid
dystrophy — see Dystrophy, choroid
hemorrhage — see Hemorrhage, choroid
rupture — see Rupture, choroid
scar — see Scar, chorioretinal
solar retinopathy — see Retinopathy, solar
specified type NEC H31.8
ciliary body — see Disorder, iris
degeneration — see Degeneration, ciliary body
citrate metabolism NEC E74.829
citrate transporter, SLC13A5 E74.820
coagulation (factor) D68.9 — see also Defect, coagulation
newborn, transient P61.6
cocaine use
mild F14.10
with
amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbances F14.122
without perceptual disturbances F14.129
cocaine-induced
anxiety disorder F14.180
bipolar and related disorder F14.14
depressive disorder F14.14
obsessive-compulsive and related disorder F14.188
psychotic disorder F14.159
sexual dysfunction F14.181
sleep disorder F14.182
cocaine intoxication delirium F14.121
in remission (early) (sustained) F14.11
moderate or severe F14.20
with
amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbances F14.222
without perceptual disturbances F14.229
cocaine-induced
anxiety disorder F14.280
bipolar and related disorder F14.24
depressive disorder F14.24
obsessive-compulsive and related disorder F14.288
psychotic disorder F14.259
sexual dysfunction F14.281
sleep disorder F14.282
cocaine intoxication delirium F14.221
in remission (early) (sustained) F14.21
coccyx NEC M53.3
cognitive F09
due to (secondary to) general medical condition F09
persisting R41.89
due to
alcohol F10.97
with dependence F10.27
anxiolytics F13.97
with dependence F13.27
hypnotics F13.97
with dependence F13.27
sedatives F13.97
with dependence F13.27
specified substance NEC F19.97
with
abuse F19.17
dependence F19.27
communication F80.9
social pragmatic F80.82
conduct (childhood) F91.9
adjustment reaction — see Disorder, adjustment
adolescent onset type F91.2
childhood onset type F91.1
compulsive F63.9
confined to family context F91.0
depressive F91.8
group type F91.2
hyperkinetic — see Disorder, attention-deficit hyperactivity
oppositional defiance F91.3
socialized F91.2
solitary aggressive type F91.1
specified NEC F91.8
unsocialized (aggressive) F91.1
conduction, heart I45.9
congenital glycosylation (CDG) E74.89
conjunctiva H11.9
infection — see Conjunctivitis
connective tissue, localized L94.9
specified NEC L94.8
conversion (functional neurological symptom disorder)
with
abnormal movement F44.4
anesthesia or sensory loss F44.6
attacks or seizures F44.5
mixed symptoms F44.7
special sensory symptoms F44.6
speech symptoms F44.4
swallowing symptoms F44.4
weakness or paralysis F44.4
convulsive (secondary) — see Convulsions
cornea H18.9
deformity — see Deformity, cornea
degeneration — see Degeneration, cornea
deposits — see Deposit, cornea
due to contact lens H18.82-
specified as edema — see Edema, cornea
edema — see Edema, cornea
keratitis — see Keratitis
keratoconjunctivitis — see Keratoconjunctivitis
membrane change — see Change, corneal membrane
neovascularization — see Neovascularization, cornea
scar — see Opacity, cornea
specified type NEC H18.89-
ulcer — see Ulcer, cornea
corpus cavernosum N48.9
cranial nerve — see Disorder, nerve, cranial
Cyclin-Dependent Kinase-Like 5 Deficiency (CDKL5) G40.42
cyclothymic F34.0
defiant oppositional F91.3
delusional (persistent) (systematized) F22
induced F24
depersonalization F48.1
depressive F32.A
due to known physiological condition
with
depressive features F06.31
major depressive-like episode F06.32
mixed features F06.34
major F32.9
with psychotic symptoms F32.3
in remission (full) F32.5
partial F32.4
recurrent F33.9
with psychotic features F33.3
single episode F32.9
mild F32.0
moderate F32.1
severe (without psychotic symptoms) F32.2
with psychotic symptoms F32.3
organic F06.31
persistent F34.1
recurrent F33.9
current episode
mild F33.0
moderate F33.1
severe (without psychotic symptoms) F33.2
with psychotic symptoms F33.3
in remission F33.40
full F33.42
partial F33.41
specified NEC F33.8
single episode — see Episode, depressive
specified NEC F32.89
developmental F89
arithmetical skills F81.2
coordination (motor) F82
expressive writing F81.81
language F80.9
expressive F80.1
mixed receptive and expressive F80.2
receptive type F80.2
specified NEC F80.89
learning F81.9
arithmetical F81.2
reading F81.0
mixed F88
motor coordination or function F82
pervasive F84.9
specified NEC F84.8
phonological F80.0
reading F81.0
scholastic skills — see also Disorder, learning
mixed F81.89
specified NEC F88
speech F80.9
articulation F80.0
specified NEC F80.89
written expression F81.81
diaphragm J98.6
digestive (system) K92.9
newborn P78.9
specified NEC P78.89
postprocedural — see Complication, gastrointestinal
psychogenic F45.8
disc (intervertebral) M51.9
with
myelopathy
cervical region M50.00
cervicothoracic region M50.03
high cervical region M50.01
lumbar region M51.06
mid-cervical region M50.020
sacrococcygeal region M53.3
thoracic region M51.04
thoracolumbar region M51.05
radiculopathy
cervical region M50.10
cervicothoracic region M50.13
high cervical region M50.11
lumbar region M51.16
lumbosacral region M51.17
mid-cervical region M50.120
sacrococcygeal region M53.3
thoracic region M51.14
thoracolumbar region M51.15
cervical M50.90
with
myelopathy M50.00
C2-C3 M50.01
C3-C4 M50.01
C4-C5 M50.021
C5-C6 M50.022
C6-C7 M50.023
C7-T1 M50.03
cervicothoracic region M50.03
high cervical region M50.01
mid-cervical region M50.020
neuritis, radiculitis or radiculopathy M50.10
C2-C3 M50.11
C3-C4 M50.11
C4-C5 M50.121
C5-C6 M50.122
C6-C7 M50.123
C7-T1 M50.13
cervicothoracic region M50.13
high cervical region M50.11
mid-cervical region M50.120
C2-C3 M50.91
C3-C4 M50.91
C4-C5 M50.921
C5-C6 M50.922
C6-C7 M50.923
C7-T1 M50.93
cervicothoracic region M50.93
degeneration M50.30
C2-C3 M50.31
C3-C4 M50.31
C4-C5 M50.321
C5-C6 M50.322
C6-C7 M50.323
C7-T1 M50.33
cervicothoracic region M50.33
high cervical region M50.31
mid-cervical region M50.320
displacement M50.20
C2-C3 M50.21
C3-C4 M50.21
C4-C5 M50.221
C5-C6 M50.222
C6-C7 M50.223
C7-T1 M50.23
cervicothoracic region M50.23
high cervical region M50.21
mid-cervical region M50.220
high cervical region M50.91
mid-cervical region M50.920
specified type NEC M50.80
C2-C3 M50.81
C3-C4 M50.81
C4-C5 M50.821
C5-C6 M50.822
C6-C7 M50.823
C7-T1 M50.83
cervicothoracic region M50.83
high cervical region M50.81
mid-cervical region M50.820
specified NEC
lumbar region M51.86
lumbosacral region M51.87
sacrococcygeal region M53.3
thoracic region M51.84
thoracolumbar region M51.85
disinhibited attachment (childhood) F94.2
disintegrative, childhood NEC F84.3
disruptive F91.9
mood dysregulation F34.81
specified NEC F91.8
disruptive behavior — see Disorder, conduct
dissocial personality F60.2
dissociative F44.9
affecting
motor function F44.4
and sensation F44.7
sensation F44.6
and motor function F44.7
brief reactive F43.0
due to (secondary to) general medical condition F06.8
mixed F44.7
organic F06.8
other specified NEC F44.89
double heterozygous sickling — see Disease, sickle-cell
dream anxiety F51.5
drug induced hemorrhagic D68.32
drug related F19.99
abuse — see Abuse, drug
dependence — see Dependence, drug
dysmorphic body F45.22
dysthymic F34.1
ear H93.9-
bleeding — see Otorrhagia
deafness — see Deafness
degenerative H93.09-
discharge — see Otorrhea
external H61.9-
auditory canal stenosis — see Stenosis, external ear canal
exostosis — see Exostosis, external ear canal
impacted cerumen — see Impaction, cerumen
otitis — see Otitis, externa
perichondritis — see Perichondritis, ear
pinna — see Disorder, pinna
specified type NEC H61.89-
in diseases classified elsewhere H62.8X-
inner H83.9-
vestibular dysfunction — see Disorder, vestibular function
middle H74.9-
adhesive H74.1-
ossicle — see Abnormal, ear ossicles
polyp — see Polyp, ear (middle)
specified NEC, in diseases classified elsewhere H75.8-
postprocedural — see Complications, ear, procedure
specified NEC, in diseases classified elsewhere H94.8-
eating (adult) (psychogenic) F50.9
anorexia — see Anorexia
binge F50.81-
bulimia F50.2-
child F98.29
pica (in remission) F98.3
rumination disorder (in remission) F98.21
pica F50.89
adult (in remission) F50.83
childhood (in remission) F98.3
rumination R11.10 — see also Rumination
adult (in remission) F50.84
infancy or childhood (in remission) F98.21
specified NEC F50.89
electrolyte (balance) NEC E87.8
with
abortion — see Abortion by type complicated by specified condition NEC
ectopic pregnancy O08.5
molar pregnancy O08.5
acidosis (lactic) (metabolic) E87.20
acute E87.21
chronic E87.22
respiratory E87.29
specified NEC E87.29
alkalosis (metabolic) (respiratory) E87.3
elimination, transepidermal L87.9
specified NEC L87.8
emotional (persistent) F34.9
of childhood F93.9
specified NEC F93.8
endocrine E34.9
postprocedural E89.89
specified NEC E89.89
erectile (male) (organic) N52.9 — see also Dysfunction, sexual, male, erectile
nonorganic F52.21
erythematous — see Erythema
esophagus K22.9
functional K22.4
psychogenic F45.8
eustachian tube H69.9-
infection — see Salpingitis, eustachian
obstruction — see Obstruction, eustachian tube
patulous — see Patulous, eustachian tube
specified NEC H69.8-
exhibitionistic F65.2
extrapyramidal G25.9
in diseases classified elsewhere
specified type NEC G25.89
eye H57.9
postprocedural — see Complication, postprocedural, eye
eyelid H02.9
cyst — see Cyst, eyelid
degenerative H02.70
chloasma — see Chloasma, eyelid
madarosis — see Madarosis
specified type NEC H02.79
vitiligo — see Vitiligo, eyelid
xanthelasma — see Xanthelasma
dermatochalasis — see Dermatochalasis
edema — see Edema, eyelid
elephantiasis — see Elephantiasis, eyelid
foreign body, retained — see Foreign body, retained, eyelid
function H02.59
abnormal innervation syndrome — see Syndrome, abnormal innervation
blepharochalasis — see Blepharochalasis
blepharoclonus — see Blepharoclonus
blepharophimosis — see Blepharophimosis
blepharoptosis — see Blepharoptosis
lagophthalmos — see Lagophthalmos
lid retraction — see Retraction, lid
hypertrichosis — see Hypertrichosis, eyelid
specified type NEC H02.89
vascular H02.879
left H02.876
lower H02.875
upper H02.874
right H02.873
lower H02.872
upper H02.871
factitious
by proxy F68.A
imposed on another F68.A
imposed on self F68.10
with predominantly
psychological symptoms F68.11
with physical symptoms F68.13
physical symptoms F68.12
with psychological symptoms F68.13
factor, coagulation — see Defect, coagulation
fatty acid
metabolism E71.30
specified NEC E71.39
oxidation
LCAD E71.310
MCAD E71.311
SCAD E71.312
specified deficiency NEC E71.318
feeding (infant or child) R63.30 — see also Disorder, eating
pediatric
acute R63.31
chronic R63.32
or eating disorder F50.9
specified NEC F50.9
feigned (with obvious motivation) Z76.5
without obvious motivation — see Disorder, factitious
female
hypoactive sexual desire F52.0
orgasmic F52.31
sexual interest/arousal F52.22
fetishistic F65.0
fibroblastic M72.9
specified NEC M72.8
fluency
adult onset F98.5
childhood onset F80.81
following
cerebral infarction I69.323
cerebrovascular disease I69.923
specified disease NEC I69.823
intracerebral hemorrhage I69.123
nontraumatic intracranial hemorrhage NEC I69.223
subarachnoid hemorrhage I69.023
in conditions classified elsewhere R47.82
fluid balance E87.8
follicular (skin) L73.9
specified NEC L73.8
FOXG1-related QA0.0151
frotteuristic F65.81
fructose metabolism E74.10
essential fructosuria E74.11
fructokinase deficiency E74.11
fructose-1, 6-diphosphatase deficiency E74.19
hereditary fructose intolerance E74.12
other specified E74.19
functional polymorphonuclear neutrophils D71.9
specified NEC D71.8
gallbladder, biliary tract and pancreas in diseases classified elsewhere K87
gambling F63.0
gamma aminobutyric acid (GABA) metabolism E72.81
gamma-glutamyl cycle E72.89
gastric (functional) K31.9
motility K30
psychogenic F45.8
secretion K30
gastrointestinal (functional) NOS K92.9
newborn P78.9
psychogenic F45.8
gender incongruence F64.9
in adolescents and adults F64.0
of childhood F64.2
gender-identity or -role F64.9
childhood F64.2
effect on relationship F66
in remission F64.A
of adolescence or adulthood F64.0
nontranssexual F64.8
specified NEC F64.8
uncertainty F66
genito-pelvic pain penetration F52.6
genitourinary system
female N94.9
male N50.9
psychogenic F45.8
globe H44.9
degenerated condition H44.50
absolute glaucoma H44.51-
atrophy H44.52-
leucocoria H44.53-
degenerative H44.30
chalcosis H44.31-
myopia H44.2- — see also Myopia, degenerative
siderosis H44.32-
specified type NEC H44.39-
endophthalmitis — see Endophthalmitis
foreign body, retained — see Foreign body, intraocular, old, retained
hemophthalmos — see Hemophthalmos
hypotony H44.40
due to
ocular fistula H44.42-
specified disorder NEC H44.43-
flat anterior chamber H44.41-
primary H44.44-
luxation — see Luxation, globe
specified type NEC H44.89
glomerular (in) N05.9
amyloidosis E85.4
cryoglobulinemia D89.1
disseminated intravascular coagulation D65
Fabry's disease E75.21
familial lecithin cholesterol acyltransferase deficiency E78.6
Goodpasture's syndrome M31.0
hemolytic-uremic syndrome — see Syndrome, hemolytic-uremic
Henoch (-Schönlein) purpura D69.0
malariae malaria B52.0
microscopic polyangiitis M31.7
multiple myeloma C90.0-
mumps B26.83
schistosomiasis B65.9
sepsis NEC A41.-
streptococcal A40.-
sickle-cell disorders D57.-
strongyloidiasis B78.9
subacute bacterial endocarditis I33.0
syphilis A52.75
systemic lupus erythematosus M32.14
thrombotic thrombocytopenic purpura M31.19
Waldenström macroglobulinemia C88.0-
Wegener's granulomatosis M31.31
gluconeogenesis E74.4
glucosaminoglycan metabolism — see Disorder, metabolism, glucosaminoglycan
glucose transport E74.819
specified NEC E74.818
glycine metabolism E72.50
d-glycericacidemia E72.59
hyperhydroxyprolinemia E72.59
hyperoxaluria R82.992
dietary E72.540
enteric E72.541
primary E72.539
specified type NEC E72.538
type 1 E72.530
type 2 E72.538
type 3 E72.538
secondary E72.549
specified type NEC E72.548
hyperprolinemia E72.59
non-ketotic hyperglycinemia E72.51
oxalosis E72.53
oxaluria E72.53
sarcosinemia E72.59
trimethylaminuria E72.52
glycoprotein metabolism E77.9
specified NEC E77.8
grief
complicated F43.81
prolonged F43.81
habit (and impulse) F63.9
involving sexual behavior NEC F65.9
specified NEC F63.89
hallucinogen use
mild F16.10
with
hallucinogen-induced
anxiety disorder F16.180
bipolar and related disorder F16.14
depressive disorder F16.14
psychotic disorder F16.159
hallucinogen intoxication delirium F16.121
other hallucinogen intoxication F16.129
in remission (early) (sustained) F16.11
moderate or severe F16.20
with
hallucinogen-induced
anxiety disorder F16.280
bipolar and related disorder F16.24
depressive disorder F16.24
psychotic disorder F16.259
hallucinogen intoxication delirium F16.221
other hallucinogen intoxication F16.229
in remission (early) (sustained) F16.21
heart action I49.9
hematological D75.9
newborn (transient) P61.9
specified NEC P61.8
hematopoietic organs D75.9
hemorrhagic NEC D69.9
drug-induced D68.32
due to
extrinsic circulating anticoagulants D68.32
increase in
anti-IIa D68.32
anti-Xa D68.32
intrinsic
circulating anticoagulants D68.318
increase in
antithrombin D68.318
anti-VIIIa D68.318
anti-IXa D68.318
anti-XIa D68.318
following childbirth O72.3
hemostasis — see Defect, coagulation
histidine metabolism E70.40
histidinemia E70.41
other specified E70.49
hoarding F42.3
hyperkinetic — see Disorder, attention-deficit hyperactivity
hyperleucine-isoleucinemia E71.19
hypervalinemia E71.19
hypoactive sexual desire F52.0
hypochondriacal F45.20
body dysmorphic F45.22
neurosis F45.21
other specified F45.29
identity
dissociative F44.81
of childhood F93.8
illness anxiety F45.21
immune mechanism (immunity) D89.9
specified type NEC D89.89
impaired renal tubular function N25.9
specified NEC N25.89
impulse (control) F63.9
inflammatory
pelvic, in diseases classified elsewhere
penis N48.29
abscess N48.21
cellulitis N48.22
inhalant use
mild F18.10
with
inhalant-induced
anxiety disorder F18.180
depressive disorder F18.14
major neurocognitive disorder F18.17
mild neurocognitive disorder F18.188
psychotic disorder F18.159
inhalant intoxication F18.129
inhalant intoxication delirium F18.121
in remission (early) (sustained) F18.11
moderate or severe F18.20
with
inhalant-induced
anxiety disorder F18.280
depressive disorder F18.24
major neurocognitive disorder F18.27
mild neurocognitive disorder F18.288
psychotic disorder F18.259
inhalant intoxication F18.229
inhalant intoxication delirium F18.221
in remission (early) (sustained) F18.21
integument, newborn P83.9
specified NEC P83.88
intermittent explosive F63.81
internal secretion pancreas — see Increased, secretion, pancreas, endocrine
intestine, intestinal
carbohydrate absorption NEC E74.39
postoperative K91.2
functional NEC K59.9
postoperative K91.89
psychogenic F45.8
vascular K55.9
chronic K55.1
specified NEC K55.8
intraoperative (intraprocedural) — see Complications, intraoperative
involuntary emotional expression (IEED) F48.2
iris H21.9
adhesions — see Adhesions, iris
atrophy — see Atrophy, iris
chamber angle recession — see Recession, chamber angle
cyst — see Cyst, iris
degeneration — see Degeneration, iris
in diseases classified elsewhere H22
iridodialysis — see Iridodialysis
iridoschisis — see Iridoschisis
miotic pupillary cyst — see Cyst, pupillary
pupillary
abnormality — see Abnormality, pupillary
membrane — see Membrane, pupillary
specified type NEC H21.89
vascular NEC H21.1X-
iron metabolism E83.10
specified NEC E83.19
isovaleric acidemia E71.110
jaw, developmental M27.0
temporomandibular M26.60- — see also Anomaly, dentofacial, temporomandibular joint
joint M25.9
derangement — see Derangement, joint
effusion — see Effusion, joint
fistula — see Fistula, joint
hemarthrosis — see Hemarthrosis
instability — see Instability, joint
osteophyte — see Osteophyte
pain — see Pain, joint
psychogenic F45.8
specified type NEC M25.80
ankle M25.87-
elbow M25.82-
foot joint M25.87-
hand joint M25.84-
hip M25.85-
knee M25.86-
shoulder M25.81-
wrist M25.83-
stiffness — see Stiffness, joint
ketone metabolism E71.32
kidney N28.9
functional (tubular) N25.9
in
schistosomiasis B65.9
tubular function N25.9
specified NEC N25.89
lacrimal system H04.9
changes H04.69
fistula — see Fistula, lacrimal
gland H04.19
atrophy — see Atrophy, lacrimal gland
cyst — see Cyst, lacrimal, gland
dacryops — see Dacryops
dislocation — see Dislocation, lacrimal gland
dry eye syndrome — see Syndrome, dry eye
infection — see Dacryoadenitis
granuloma — see Granuloma, lacrimal
inflammation — see Inflammation, lacrimal
obstruction — see Obstruction, lacrimal
specified NEC H04.89
lactation NEC O92.79
language (developmental) F80.9
expressive F80.1
mixed receptive and expressive F80.2
receptive F80.2
late luteal phase dysphoric N94.89
learning (specific) F81.9
acalculia R48.8
alexia R48.0
mathematics F81.2
reading F81.0
specified
with impairment in
mathematics F81.2
reading F81.0
written expression F81.81
specified NEC F81.89
spelling F81.81
written expression F81.81
lens H27.9
aphakia — see Aphakia
cataract — see Cataract
dislocation — see Dislocation, lens
specified type NEC H27.8
ligament M24.20
ankle M24.27-
attachment, spine — see Enthesopathy, spinal
elbow M24.22-
foot joint M24.27-
hand joint M24.24-
hip M24.25-
knee — see Derangement, knee, specified NEC
shoulder M24.21-
specified site NEC M24.29
vertebra M24.28
wrist M24.23-
ligamentous attachments — see also Enthesopathy
spine — see Enthesopathy, spinal
lipid
metabolism, congenital E78.9
storage E75.6
specified NEC E75.5
lipoprotein
deficiency (familial) E78.6
metabolism E78.9
specified NEC E78.89
liver K76.9
malarial B54
low back — see also Dorsopathy, specified NEC
lumbosacral
plexus G54.1
root (nerve) NEC G54.4
lung, interstitial, drug-induced J70.4
acute J70.2
chronic J70.3
dabbing (related) U07.0
e-cigarette (related) U07.0
electronic cigarette (related) U07.0
vaping (associated) (device) (product) (related) (use) U07.0
lymphoproliferative, post-transplant (PTLD) D47.Z1
lysine and hydroxylysine metabolism E72.3
major neurocognitive F03- — see also Dementia, in (due to)
male
erectile (organic) N52.9 — see also Dysfunction, sexual, male, erectile
nonorganic F52.21
hypoactive sexual desire F52.0
orgasmic F52.32
manic F30.9
organic F06.33
mast cell activation — see Activation, mast cell
mastoid — see also Disorder, ear, middle
postprocedural — see Complications, ear, procedure
meninges, specified type NEC G96.198
meniscus — see Derangement, knee, meniscus
menopausal N95.9
specified NEC N95.8
menstrual N92.6
psychogenic F45.8
specified NEC N92.5
mental (or behavioral) (nonpsychotic) F99
due to (secondary to)
amphetamine
due to drug abuse — see Abuse, drug, stimulant
due to drug dependence — see Dependence, drug, stimulant
brain disease, damage and dysfunction F09
caffeine use
due to drug abuse — see Abuse, drug, stimulant
due to drug dependence — see Dependence, drug, stimulant
cannabis use
due to drug abuse — see Abuse, drug, cannabis
due to drug dependence — see Dependence, drug, cannabis
general medical condition F09
sedative or hypnotic use
due to drug abuse — see Abuse, drug, sedative
due to drug dependence — see Dependence, drug, sedative
tobacco (nicotine) use — see Dependence, drug, nicotine
following organic brain damage F07.9
frontal lobe syndrome F07.0
personality change F07.0
postconcussional syndrome F07.81
specified NEC F07.89
infancy, childhood or adolescence F98.9
neurotic — see Neurosis
organic or symptomatic F09
presenile, psychotic F03
problem NEC
psychoneurotic — see Neurosis
psychotic — see Psychosis
puerperal F53.0
senile, psychotic NEC F03
metabolic, amino acid, transitory, newborn P74.8
metabolism NOS E88.9
amino-acid E72.9
aromatic E70.9
albinism — see Albinism
histidine E70.40
histidinemia E70.41
other specified E70.49
hyperphenylalaninemia E70.1
classical phenylketonuria E70.0
other specified E70.89
tryptophan E70.5
tyrosine E70.20
hypertyrosinemia E70.21
other specified E70.29
branched chain E71.2
3-methylglutaconic aciduria E71.111
hyperleucine-isoleucinemia E71.19
hypervalinemia E71.19
isovaleric acidemia E71.110
maple syrup urine disease E71.0
methylmalonic acidemia E71.120
organic aciduria NEC E71.118
other specified E71.19
propionate NEC E71.128
propionic acidemia E71.121
glycine E72.50
d-glycericacidemia E72.59
hyperhydroxyprolinemia E72.59
hyperoxaluria R82.992
primary E72.53
hyperprolinemia E72.59
non-ketotic hyperglycinemia E72.51
other specified E72.59
sarcosinemia E72.59
trimethylaminuria E72.52
hydroxylysine E72.3
lysine E72.3
ornithine E72.4
other specified E72.89
beta-amino acid E72.89
gamma-glutamyl cycle E72.89
straight-chain E72.89
sulfur-bearing E72.10
homocystinuria E72.11
methylenetetrahydrofolate reductase deficiency E72.12
other specified E72.19
bile acid and cholesterol metabolism E78.70
bilirubin E80.7
specified NEC E80.6
calcium E83.50
hypercalcemia E83.52
hypocalcemia E83.51
other specified E83.59
carbohydrate E74.9
specified NEC E74.89
cholesterol and bile acid metabolism E78.70
citrate NEC E74.829
congenital E88.9
copper E83.00
Wilson's disease E83.01
specified type NEC E83.09
cystinuria E72.01
fructose E74.10
galactose E74.20
glucosaminoglycan E76.9
mucopolysaccharidosis — see Mucopolysaccharidosis
specified NEC E76.8
glutamine E72.89
glycine E72.50
glycogen storage (hepatorenal) E74.09
glycoprotein E77.9
specified NEC E77.8
glycosaminoglycan E76.9
specified NEC E76.8
in labor and delivery O75.89
iron E83.10
isoleucine E71.19
leucine E71.19
lipoid E78.9
lipoprotein E78.9
specified NEC E78.89
magnesium E83.40
hypermagnesemia E83.41
hypomagnesemia E83.42
other specified E83.49
mineral E83.9
specified NEC E83.89
mitochondrial E88.40
aminoacyl-tRNA synthetase E88.43
ARS2-related E88.43
MELAS syndrome E88.41
MERRF syndrome (myoclonic epilepsy associated with ragged-red fibers) E88.42
other specified E88.49
tRNA synthetases E88.43
ornithine E72.4
phosphatases E83.30
phosphorus E83.30
acid phosphatase deficiency E83.39
hypophosphatasia E83.39
hypophosphatemia E83.39
familial E83.31
other specified E83.39
pseudovitamin D deficiency E83.32
plasma protein NEC E88.09
porphyrin — see Porphyria
postprocedural E89.89
specified NEC E89.89
purine E79.9
specified NEC E79.89
pyrimidine E79.9
specified NEC E79.89
pyruvate E74.4
serine E72.89
sodium E87.8
specified NEC E88.89
threonine E72.89
valine E71.19
zinc E83.2
methylmalonic acidemia E71.120
micturition NEC R39.198 — see also Difficulty, micturition
feeling of incomplete emptying R39.14
hesitancy R39.11
poor stream R39.12
psychogenic F45.8
split stream R39.13
straining R39.16
urgency R39.15
mild neurocognitive G31.84
due to known physiological condition (without behavioral disturbance) F06.70
with behavioral disturbance F06.71
mitochondrial metabolism E88.40
mitral (valve) — see Endocarditis, mitral
mixed
anxiety and depressive F41.8
of scholastic skills (developmental) F81.89
receptive expressive language F80.2
mood F39
bipolar — see Disorder, bipolar
depressive — see Disorder, depressive
due to (secondary to)
alcohol F10.94
amphetamine F15.94
in
abuse F15.14
dependence F15.24
anxiolytic F13.94
in
abuse F13.14
dependence F13.24
cocaine F14.94
in
abuse F14.14
dependence F14.24
general medical condition F06.30
hallucinogen F16.94
in
abuse F16.14
dependence F16.24
hypnotic F13.94
in
abuse F13.14
dependence F13.24
inhalant F18.94
in
abuse F18.14
dependence F18.24
opioid F11.94
in
abuse F11.14
dependence F11.24
phencyclidine (PCP) F16.94
in
abuse F16.14
dependence F16.24
physiological condition F06.30
with
depressive features F06.31
major depressive-like episode F06.32
manic features F06.33
mixed features F06.34
psychoactive substance NEC F19.94
in
abuse F19.14
dependence F19.24
sedative F13.94
in
abuse F13.14
dependence F13.24
volatile solvents F18.94
in
abuse F18.14
dependence F18.24
manic episode F30.9
with psychotic symptoms F30.2
in remission (full) F30.4
partial F30.3
specified type NEC F30.8
without psychotic symptoms F30.10
mild F30.11
moderate F30.12
severe F30.13
organic F06.30
right hemisphere F07.89
persistent F34.9
cyclothymia F34.0
dysthymia F34.1
specified type NEC F34.89
recurrent F39
right hemisphere organic F07.89
movement G25.9
drug-induced G25.70
akathisia G25.71
specified NEC G25.79
hysterical F44.4
in diseases classified elsewhere
periodic limb G47.61
sleep related G47.61
specified NEC G25.89
sleep related NEC G47.69
stereotyped F98.4
treatment-induced G25.9
multiple personality F44.81
muscle M62.9
attachment, spine — see Enthesopathy, spinal
in trichinellosis — see Trichinellosis, with muscle disorder
psychogenic F45.8
specified type NEC M62.89
tone, newborn P94.9
specified NEC P94.8
muscular
attachments — see also Enthesopathy
spine — see Enthesopathy, spinal
urethra N36.44
musculoskeletal system, soft tissue — see Disorder, soft tissue
postprocedural M96.89
psychogenic F45.8
myoneural G70.9
due to lead G70.1
specified NEC G70.89
toxic G70.1
myotonic NEC G71.19
nail, in diseases classified elsewhere L62
neck region NEC — see Dorsopathy, specified NEC
neonatal onset multisystemic inflammatory (NOMID) M04.2
nerve G58.9
abducent NEC — see Strabismus, paralytic, sixth nerve
accessory G52.8
acoustic
auditory
auriculotemporal G50.8
axillary G54.0
cerebral — see Disorder, nerve, cranial
cranial G52.9
eighth
eleventh G52.8
fifth G50.9
first G52.0
fourth NEC — see Strabismus, paralytic, fourth nerve
multiple G52.7
ninth G52.1
second NEC — see Disorder, nerve, optic
seventh NEC G51.8
sixth NEC — see Strabismus, paralytic, sixth nerve
specified NEC G52.8
tenth G52.2
third NEC — see Strabismus, paralytic, third nerve
twelfth G52.3
entrapment — see Neuropathy, entrapment
facial G51.9
specified NEC G51.8
femoral — see Lesion, nerve, femoral
glossopharyngeal NEC G52.1
hypoglossal G52.3
intercostal G58.0
lateral
cutaneous of thigh — see Mononeuropathy, lower limb, meralgia paresthetica
popliteal — see Lesion, nerve, popliteal
lower limb — see Mononeuropathy, lower limb
medial popliteal — see Lesion, nerve, popliteal, medial
median NEC — see Lesion, nerve, median
multiple G58.7
oculomotor NEC — see Strabismus, paralytic, third nerve
olfactory G52.0
optic NEC H47.09-
hemorrhage into sheath — see Hemorrhage, optic nerve
ischemic H47.01-
peroneal — see Lesion, nerve, popliteal
phrenic G58.8
plantar — see Lesion, nerve, plantar
pneumogastric G52.2
posterior tibial — see Syndrome, tarsal tunnel
radial — see Lesion, nerve, radial
recurrent laryngeal G52.2
root G54.9
cervical G54.2
lumbosacral G54.1
specified NEC G54.8
thoracic G54.3
sciatic NEC — see Lesion, nerve, sciatic
specified NEC G58.8
lower limb — see Mononeuropathy, lower limb, specified NEC
upper limb — see Mononeuropathy, upper limb, specified NEC
sympathetic G90.9
tibial — see Lesion, nerve, popliteal, medial
trigeminal G50.9
specified NEC G50.8
trochlear NEC — see Strabismus, paralytic, fourth nerve
ulnar — see Lesion, nerve, ulnar
upper limb — see Mononeuropathy, upper limb
vagus G52.2
nervous system G98.8
autonomic (peripheral) G90.9
specified NEC G90.89
central G96.9
specified NEC G96.89
parasympathetic G90.9
specified NEC G98.8
sympathetic G90.9
vegetative G90.9
neurocognitive R41.9
with Lewy bodies G31.83 — see also Dementia, in, diseases specified elsewhere
frontotemporal, specified NEC G31.09 — see also Dementia, in, diseases specified elsewhere
major F03.- — see also Dementia
due to vascular disease — see Dementia, vascular
mild — see Dementia, vascular, mild
moderate — see Dementia, vascular, moderate
severe — see Dementia, vascular, severe
in (due to) (other diseases classified elsewhere) F02.80 — see also Dementia, in (due to)
with
aggressive behavior F02.81- — see also Dementia, in (due to)
combative behavior F02.81- — see also Dementia, in (due to)
violent behavior F02.81- — see also Dementia, in (due to)
mild (of uncertain or unknown etiology) G31.84 — see also Disorder, mild neurocognitive
neurodevelopmental F89
CACNA1A-related QA0.0102
DLG4-related synaptopathy QA0.0142
FOXG1-related QA0.0151
GRIN1-related QA0.011
GRIN2A-related QA0.011
GRIN2B-related QA0.011
GRIN2D-related QA0.011
GRIA1-related QA0.011
GRIA2-related QA0.011
GRIA3-related QA0.011
GRIA4-related QA0.011
GRIK2-related QA0.011
other
glutamate receptor, ionotropic, related QA0.011
ion channel gene related QA0.0109
receptor gene related QA0.012
related to other genes associated with transcription and gene expression QA0.0159
synapse related gene QA0.0149
transporter or solute carrier gene related QA0.0139
SCN2A-related QA0.0101
SLC6A1-related QA0.0131
STXBP1-related QA0.0141
syntaxin-binding protein 1-related QA0.0141
specified NEC F88
related to pathogenic variants in specific genes NEC QA0.8
neurohypophysis NEC E23.3
neurological NEC R29.818
TUBB4A-related G23.3
neuromuscular G70.9
hereditary NEC G71.9
specified NEC G70.89
toxic G70.1
neurotic F48.9
specified NEC F48.8
neutrophil, polymorphonuclear D71.9
specified NEC D71.8
nicotine use — see Dependence, drug, nicotine
nightmare F51.5
non-rapid eye movement sleep arousal
sleep terror type F51.4
sleepwalking type F51.3
nose J34.9
specified NEC J34.89
obsessive-compulsive F42.9
and related disorder due to a known physiological condition F06.8
odontogenesis NOS K00.9
opioid use
with
opioid-induced psychotic disorder F11.959
with
delusions F11.950
hallucinations F11.951
due to drug abuse — see Abuse, drug, opioid
due to drug dependence — see Dependence, drug, opioid
mild F11.10
with
opioid-induced
anxiety disorder F11.188
depressive disorder F11.14
sexual dysfunction F11.181
opioid intoxication
with perceptual disturbances F11.122
delirium F11.121
without perceptual disturbances F11.129
in remission (early) (sustained) F11.11
moderate or severe F11.20
with
opioid-induced
anxiety disorder F11.288
depressive disorder F11.24
sexual dysfunction F11.281
opioid intoxication
with perceptual disturbances F11.222
delirium F11.221
without perceptual disturbances F11.229
in remission (early) (sustained) F11.21
oppositional defiant F91.3
optic
chiasm H47.49
due to
inflammatory disorder H47.41
neoplasm H47.42
vascular disorder H47.43
disc H47.39-
coloboma — see Coloboma, optic disc
drusen — see Drusen, optic disc
pseudopapilledema — see Pseudopapilledema
radiations — see Disorder, visual, pathway
tracts — see Disorder, visual, pathway
orbit H05.9
cyst — see Cyst, orbit
deformity — see Deformity, orbit
edema — see Edema, orbit
enophthalmos — see Enophthalmos
exophthalmos — see Exophthalmos
hemorrhage — see Hemorrhage, orbit
inflammation — see Inflammation, orbit
myopathy — see Myopathy, extraocular muscles
retained foreign body — see Foreign body, orbit, old
specified type NEC H05.89
organic
anxiety F06.4
catatonic NOS F06.1
delusional F06.2
dissociative F06.8
emotionally labile (asthenic) F06.8
mood (affective) F06.30
schizophrenia-like F06.2
orgasmic (female) F52.31
male F52.32
ornithine metabolism E72.4
overanxious F41.1
of childhood F93.8
pain
with related psychological factors F45.42
exclusively related to psychological factors F45.41
genito-pelvic penetration disorder F52.6
pancreatic internal secretion E16.9
specified NEC E16.8
panic F41.0
with agoraphobia F40.01
papulosquamous L44.9
in diseases classified elsewhere L45
specified NEC L44.8
paranoid F22
induced F24
shared F24
paraphilic F65.9
specified NEC F65.89
parathyroid (gland) E21.5
specified NEC E21.4
parietoalveolar NEC J84.09
paroxysmal, mixed R56.9
patella M22.9-
chondromalacia — see Chondromalacia, patella
derangement NEC M22.3X-
recurrent
dislocation — see Dislocation, patella, recurrent
subluxation — see Dislocation, patella, recurrent, incomplete
specified NEC M22.8X-
patellofemoral M22.2X-
pedophilic F65.4
pentose phosphate pathway with anemia D55.1
perception, due to hallucinogens F16.983
in
abuse F16.183
dependence F16.283
peripheral nervous system NEC G64
peroxisomal E71.50
biogenesis
neonatal adrenoleukodystrophy E71.511
specified disorder NEC E71.518
Zellweger syndrome E71.510
rhizomelic chondrodysplasia punctata E71.540
specified form NEC E71.548
group 1 E71.518
group 2 E71.53
group 3 E71.542
X-linked adrenoleukodystrophy E71.529
adolescent E71.521
adrenomyeloneuropathy E71.522
childhood E71.520
specified form NEC E71.528
Zellweger-like syndrome E71.541
persistent
(somatoform) pain F45.41
affective (mood) F34.9
personality F60.9 — see also Personality
affective F34.0
aggressive F60.3
amoral F60.2
anankastic F60.5
antisocial F60.2
anxious F60.6
asocial F60.2
asthenic F60.7
avoidant F60.6
borderline F60.3
change (secondary) due to general medical condition F07.0
compulsive F60.5
cyclothymic F34.0
dependent (passive) F60.7
depressive F34.1
dissocial F60.2
emotional instability F60.3
expansive paranoid F60.0
explosive F60.3
following organic brain damage F07.9
histrionic F60.4
hyperthymic F34.0
hypothymic F34.1
hysterical F60.4
immature F60.89
inadequate F60.7
labile F60.3
mixed (nonspecific) F60.89
moral deficiency F60.2
narcissistic F60.81
negativistic F60.89
obsessional F60.5
obsessive (-compulsive) F60.5
organic F07.9
overconscientious F60.5
paranoid F60.0
passive (-dependent) F60.7
passive-aggressive F60.89
pathological NEC F60.9
pseudosocial F60.2
psychopathic F60.2
schizoid F60.1
schizotypal F21
self-defeating F60.7
specified NEC F60.89
type A F60.5
unstable (emotional) F60.3
pervasive, developmental F84.9
phencyclidine use
mild F16.10
with
phencyclidine-induced
anxiety disorder F16.180
bipolar and related disorder F16.14
depressive disorder F16.14
psychotic disorder F16.159
phencyclidine intoxication F16.129
phencyclidine intoxication delirium F16.121
in remission (early) (sustained) F16.11
moderate or severe F16.20
with
phencyclidine-induced
anxiety disorder F16.280
bipolar and related disorder F16.24
depressive disorder F16.24
psychotic disorder F16.259
phencyclidine intoxication F16.229
phencyclidine intoxication delirium F16.221
in remission (early) (sustained) F16.21
phobic anxiety, childhood F40.8
phosphate-losing tubular N25.0
pigmentation L81.9
choroid, congenital Q14.3
diminished melanin formation L81.6
iron L81.8
specified NEC L81.8
pinna (noninfective) H61.10-
deformity, acquired H61.11-
hematoma H61.12-
perichondritis — see Perichondritis, ear
specified type NEC H61.19-
pituitary gland E23.7
iatrogenic (postprocedural) E89.3
specified NEC E23.6
platelet-activating anti-PF4, specified NEC D75.84
platelets D69.19
plexus G54.9
specified NEC G54.8
polymorphonuclear neutrophils D71.9
specified NEC D71.8
porphyrin metabolism — see Porphyria
postconcussional F07.81
posthallucinogen perception F16.983
in
abuse F16.183
dependence F16.283
postmenopausal N95.9
specified NEC N95.8
postprocedural (postoperative) — see Complications, postprocedural
post-transplant lymphoproliferative D47.Z1
post-traumatic stress (PTSD) F43.10
acute F43.11
chronic F43.12
premenstrual dysphoric (PMDD) F32.81
prepuce N47.8
propionic acidemia E71.121
prostate N42.9
specified NEC N42.89
psychogenic NOS F45.9 — see also condition
anxiety F41.8
appetite F50.9
asthenic F48.8
cardiovascular (system) F45.8
compulsive F42.8
cutaneous F54
depressive F32.9
digestive (system) F45.8
dysmenorrheic F45.8
dyspneic F45.8
endocrine (system) F54
eye NEC F45.8
feeding — see Disorder, eating
functional NEC F45.8
gastric F45.8
gastrointestinal (system) F45.8
genitourinary (system) F45.8
heart (function) (rhythm) F45.8
hyperventilatory F45.8
hypochondriacal — see Disorder, hypochondriacal
intestinal F45.8
joint F45.8
learning F81.9
limb F45.8
lymphatic (system) F45.8
menstrual F45.8
micturition F45.8
monoplegic NEC F44.4
motor F44.4
muscle F45.8
musculoskeletal F45.8
neurocirculatory F45.8
obsessive F42.8
occupational F48.8
organ or part of body NEC F45.8
paralytic NEC F44.4
phobic F40.9
physical NEC F45.8
rectal F45.8
respiratory (system) F45.8
rheumatic F45.8
sexual (function) F52.9
skin (allergic) (eczematous) F54
sleep F51.9
specified part of body NEC F45.8
stomach F45.8
psychological F99
associated with
disease classified elsewhere F54
sexual
development F66
relationship F66
uncertainty about gender identity F64.9
psychomotor NEC F44.4
hysterical F44.4
psychoneurotic — see also Neurosis
mixed NEC F48.8
psychophysiologic — see Disorder, somatoform
psychosexual F65.9
development F66
identity of childhood F64.2
psychosomatic NOS — see Disorder, somatoform
multiple F45.0
undifferentiated F45.1
psychotic — see Psychosis
transient (acute) F23
puberty E30.9
specified NEC E30.8
pulmonary (valve) — see Endocarditis, pulmonary
purine metabolism E79.9
pyrimidine metabolism E79.9
pyruvate metabolism E74.4
reactive attachment (childhood) F94.1
reading R48.0
developmental (specific) F81.0
receptive language F80.2
receptor, hormonal, peripheral E34.50 — see also Syndrome, androgen insensitivity
recurrent brief depressive F33.8
reflex R29.2
refraction H52.7
aniseikonia H52.32
anisometropia H52.31
astigmatism — see Astigmatism
hypermetropia — see Hypermetropia
myopia — see Myopia
presbyopia H52.4
specified NEC H52.6
relationship F68.8
due to sexual orientation F66
REM sleep behavior G47.52
renal function, impaired (tubular) N25.9
resonance R49.9
specified NEC R49.8
respiratory function, impaired — see also Failure, respiration
postprocedural — see Complication, postoperative, respiratory system
psychogenic F45.8
retina H35.9
angioid streaks H35.33
changes in vascular appearance H35.01-
degeneration — see Degeneration, retina
dystrophy (hereditary) — see Dystrophy, retina
edema H35.81
hemorrhage — see Hemorrhage, retina
ischemia H35.82
macular degeneration — see Degeneration, macula
microaneurysms H35.04-
microvascular abnormality NEC H35.09
neovascularization — see Neovascularization, retina
retinopathy — see Retinopathy
separation of layers H35.70
central serous chorioretinopathy H35.71-
pigment epithelium detachment (serous) H35.72-
hemorrhagic H35.73-
specified type NEC H35.89
telangiectasis — see Telangiectasis, retina
vasculitis — see Vasculitis, retina
retroperitoneal K68.9
right hemisphere organic affective F07.89
rumination (infant or child) (in remission) F98.21
adult (in remission) F50.84
sacrum, sacrococcygeal NEC M53.3
schizoaffective F25.9
bipolar type F25.0
depressive type F25.1
manic type F25.0
mixed type F25.0
specified NEC F25.8
schizoid of childhood F84.5
schizophrenia spectrum and other psychotic disorder F29
specified NEC F28
schizophreniform F20.81
brief F23
schizotypal (personality) F21
seasonal affective, recurrent episodes F33.-
secretion, thyrocalcitonin E07.0
sedative, hypnotic, or anxiolytic use
mild F13.10
with
sedative, hypnotic, or anxiolytic-induced
anxiety disorder F13.180
bipolar and related disorder F13.14
depressive disorder F13.14
psychotic disorder F13.159
sexual dysfunction F13.181
sedative, hypnotic, or anxiolytic intoxication F13.129
sedative, hypnotic, or anxiolytic intoxication delirium F13.121
in remission (early) (sustained) F13.11
moderate or severe F13.20
with
sedative, hypnotic, or anxiolytic-induced
anxiety disorder F13.280
bipolar and related disorder F13.24
depressive disorder F13.24
major neurocognitive disorder F13.27
mild neurocognitive disorder F13.288
psychotic disorder F13.259
sexual dysfunction F13.281
sedative, hypnotic, or anxiolytic intoxication F13.229
sedative, hypnotic, or anxiolytic intoxication delirium F13.221
in remission (early) (sustained) F13.21
seizure G40.909 — see also Epilepsy
intractable G40.919
with status epilepticus G40.911
semantic pragmatic F80.89
with autism F84.0
sense of smell R43.1
psychogenic F45.8
separation anxiety, of childhood F93.0
sexual
arousal, female F52.22
aversion F52.1
function, psychogenic F52.9
interest/arousal, female F52.22
masochism F65.51
maturation F66
nonorganic F52.9
preference F65.9 — see also Deviation, sexual
fetishistic transvestism F65.1
relationship F66
sadism F65.52
shyness, of childhood and adolescence F40.10
sibling rivalry F93.8
sickle-cell (sickling) (homozygous) — see Disease, sickle-cell
heterozygous D57.3
specified type NEC D57.8-
trait D57.3
sinus (nasal) J34.9
specified NEC J34.89
skin L98.9
atrophic L90.9
specified NEC L90.8
granulomatous L92.9
specified NEC L92.8
hypertrophic L91.9
specified NEC L91.8
infiltrative NEC L98.6
newborn P83.9
specified NEC P83.88
picking F42.4
psychogenic (allergic) (eczematous) F54
SLC13A5 Citrate Transporter Disorder E74.820
sleep G47.9
breathing-related — see Apnea, sleep
circadian rhythm G47.20
advance sleep phase type G47.22
delayed sleep phase type G47.21
due to
alcohol
abuse F10.182
dependence F10.282
use F10.982
amphetamines
abuse F15.182
dependence F15.282
use F15.982
caffeine
abuse F15.182
dependence F15.282
use F15.982
cocaine
abuse F14.182
dependence F14.282
use F14.982
drug NEC
abuse F19.182
dependence F19.282
use F19.982
opioid
abuse F11.182
dependence F11.282
use F11.982
psychoactive substance NEC
abuse F19.182
dependence F19.282
use F19.982
sedative, hypnotic, or anxiolytic
abuse F13.182
dependence F13.282
use F13.982
stimulant NEC
abuse F15.182
dependence F15.282
use F15.982
free running type G47.24
in conditions classified elsewhere G47.27
irregular sleep wake type G47.23
jet lag type G47.25
non-24-hour sleep-wake type G47.24
shift work type G47.26
specified NEC G47.29
due to
alcohol
abuse F10.182
dependence F10.282
use F10.982
amphetamine
abuse F15.182
dependence F15.282
use F15.982
anxiolytic
abuse F13.182
dependence F13.282
use F13.982
caffeine
abuse F15.182
dependence F15.282
use F15.982
cocaine
abuse F14.182
dependence F14.282
use F14.982
drug NEC
abuse F19.182
dependence F19.282
use F19.982
hypnotic
abuse F13.182
dependence F13.282
use F13.982
opioid
abuse F11.182
dependence F11.282
use F11.982
psychoactive substance NEC
abuse F19.182
dependence F19.282
use F19.982
sedative
abuse F13.182
dependence F13.282
use F13.982
stimulant NEC
abuse F15.182
dependence F15.282
use F15.982
emotional F51.9
excessive somnolence — see Hypersomnia
hypersomnia type — see Hypersomnia
initiating or maintaining — see Insomnia
nightmares F51.5
nonorganic F51.9
specified NEC F51.8
parasomnia type G47.50
specified NEC G47.8
terrors F51.4
walking F51.3
sleep-wake pattern or schedule G47.9 — see also Disorder, sleep, circadian rhythm
specified NEC G47.8
social
anxiety (of childhood) F40.10
generalized F40.11
functioning in childhood F94.9
specified NEC F94.8
pragmatic F80.82
soft tissue M79.9
ankle M79.9
due to use, overuse and pressure M70.90
ankle M70.97-
bursitis — see Bursitis
foot M70.97-
forearm M70.93-
hand M70.94-
lower leg M70.96-
multiple sites M70.99
pelvic region M70.95-
shoulder region M70.91-
specified site NEC M70.98
specified type NEC M70.80
ankle M70.87-
foot M70.87-
forearm M70.83-
hand M70.84-
lower leg M70.86-
multiple sites M70.89
pelvic region M70.85-
shoulder region M70.81-
specified site NEC M70.88
thigh M70.85-
upper arm M70.82-
thigh M70.95-
upper arm M70.92-
foot M79.9
forearm M79.9
hand M79.9
lower leg M79.9
multiple sites M79.9
occupational — see Disorder, soft tissue, due to use, overuse and pressure
pelvic region M79.9
shoulder region M79.9
specified type NEC M79.89
thigh M79.9
upper arm M79.9
somatic symptom F45.1
somatization F45.0
somatoform F45.9
pain (persistent) F45.41
somatization (multiple) (long-lasting) F45.0
specified NEC F45.8
undifferentiated F45.1
somnolence, excessive — see Hypersomnia
specific
arithmetical F81.2
developmental, of motor F82
reading F81.0
speech and language F80.9
spelling F81.81
written expression F81.81
speech R47.9
articulation (functional) (specific) F80.0
developmental F80.9
specified NEC R47.89
speech-sound F80.0
spelling (specific) F81.81
spine — see also Dorsopathy
ligamentous or muscular attachments, peripheral — see Enthesopathy, spinal
specified NEC — see Dorsopathy, specified NEC
stereotyped, habit or movement F98.4
stimulant use (other) (unspecified)
mild F15.10
in remission (early) (sustained) F15.11
moderate or severe F15.20
in remission (early) (sustained) F15.21
stomach (functional) — see Disorder, gastric
stress F43.9
acute F43.0
post-traumatic F43.10
acute F43.11
chronic F43.12
substance use (other) (unknown)
mild F19.10
with substance-induced
anxiety disorder F19.180
bipolar and related disorder F19.14
depressive disorder F19.14
major neurocognitive disorder F19.17
mild neurocognitive disorder F19.188
obsessive-compulsive and related disorder F19.188
sexual dysfunction F19.181
substance intoxication F19.129
substance intoxication delirium F19.121
moderate or severe F19.20
with substance-induced
anxiety disorder F19.280
bipolar and related disorder F19.24
depressive disorder F19.24
major neurocognitive disorder F19.27
mild neurocognitive disorder F19.288
obsessive-compulsive and related disorder F19.288
sexual dysfunction F19.281
in remission (early) (sustained) F19.21
substance intoxication F19.229
substance intoxication delirium F19.221
sulfur-bearing amino-acid metabolism E72.10
sweat gland (eccrine) L74.9
apocrine L75.9
specified NEC L75.8
specified NEC L74.8
synovium M67.90
acromioclavicular M67.91-
ankle M67.97-
elbow M67.92-
foot M67.97-
forearm M67.93-
hand M67.94-
hip M67.95-
knee M67.96-
multiple sites M67.99
rupture — see Rupture, synovium
shoulder M67.91-
specified type NEC M67.80
acromioclavicular M67.81-
ankle M67.87-
elbow M67.82-
foot M67.87-
hand M67.84-
hip M67.85-
knee M67.86-
multiple sites M67.89
wrist M67.83-
synovitis — see Synovitis
upper arm M67.92-
wrist M67.93-
temperature regulation, newborn P81.9
specified NEC P81.8
temporomandibular joint M26.60-
tendon M67.90
acromioclavicular M67.91-
ankle M67.97-
contracture — see Contracture, tendon
elbow M67.92-
foot M67.97-
forearm M67.93-
hand M67.94-
hip M67.95-
knee M67.96-
multiple sites M67.99
rupture — see Rupture, tendon
shoulder M67.91-
specified type NEC M67.80
acromioclavicular M67.81-
ankle M67.87-
elbow M67.82-
foot M67.87-
hand M67.84-
hip M67.85-
knee M67.86-
multiple sites M67.89
trunk M67.88
wrist M67.83-
synovitis — see Synovitis
tendinitis — see Tendinitis
tenosynovitis — see Tenosynovitis
trunk M67.98
upper arm M67.92-
wrist M67.93-
thoracic root (nerve) NEC G54.3
thyrocalcitonin hypersecretion E07.0
thyroid (gland) E07.9
function NEC, neonatal, transitory P72.2
iodine-deficiency related E01.8
specified NEC E07.89
tic — see Tic
tobacco use
chewing tobacco (mild) (moderate) (severe)
in remission (early) (sustained) F17.221
cigarettes (mild) (moderate) (severe)
in remission (early) (sustained) F17.211
mild F17.200
in remission (early) (sustained) F17.201
moderate F17.200
in remission (early) (sustained) F17.201
severe F17.200
in remission (early) (sustained) F17.201
specified product NEC (mild) (moderate) (severe)
in remission (early) (sustained) F17.291
tooth K08.9
development K00.9
specified NEC K00.8
eruption K00.6
Tourette's F95.2
trance and possession F44.89
transvestic F65.1
trauma and stressor-related NOS F43.9
other specified F43.89
unspecified F43.9
tricuspid (valve) — see Endocarditis, tricuspid
tryptophan metabolism E70.5
tubular, phosphate-losing N25.0
tubulo-interstitial (in)
brucellosis A23.9
cystinosis E72.04
diphtheria A36.84
glycogen storage disease E74.00
leukemia NEC C95.9-
lymphoma NEC C85.9-
mixed cryoglobulinemia D89.1
multiple myeloma C90.0-
Salmonella infection A02.25
sarcoidosis D86.84
sepsis A41.9
streptococcal A40.9
systemic lupus erythematosus M32.15
toxoplasmosis B58.83
transplant rejection T86.91
Wilson's disease E83.01
tubulo-renal function, impaired N25.9
specified NEC N25.89
tympanic membrane H73.9-
atrophy — see Atrophy, tympanic membrane
infection — see Myringitis
perforation — see Perforation, tympanum
specified NEC H73.89-
unsocialized aggressive F91.1
urea cycle metabolism E72.20
argininemia E72.21
arginosuccinic aciduria E72.22
citrullinemia E72.23
ornithine transcarbamylase deficiency E72.4
other specified E72.29
ureter (in) N28.9
schistosomiasis B65.0
tuberculosis A18.11
urethra N36.9
specified NEC N36.8
urinary system N39.9
specified NEC N39.8
valve, heart
aortic — see Endocarditis, aortic
mitral — see Endocarditis, mitral
pulmonary — see Endocarditis, pulmonary
rheumatic
aortic — see Endocarditis, aortic, rheumatic
mitral — see Endocarditis, mitral
pulmonary — see Endocarditis, pulmonary, rheumatic
tricuspid — see Endocarditis, tricuspid
tricuspid — see Endocarditis, tricuspid
vestibular function H81.9-
specified NEC
in diseases classified elsewhere H82.-
vertigo — see Vertigo
vision, binocular H53.30
abnormal retinal correspondence H53.31
diplopia H53.2
fusion with defective stereopsis H53.32
simultaneous perception H53.33
suppression H53.34
visual
cortex
blindness H47.619
left brain H47.612
right brain H47.611
due to
inflammatory disorder H47.629
left brain H47.622
right brain H47.621
neoplasm H47.639
left brain H47.632
right brain H47.631
vascular disorder H47.649
left brain H47.642
right brain H47.641
pathway H47.9
due to
inflammatory disorder H47.51-
neoplasm H47.52-
vascular disorder H47.53-
optic chiasm — see Disorder, optic, chiasm
vitreous body H43.9
crystalline deposits — see Deposit, crystalline
degeneration — see Degeneration, vitreous
hemorrhage — see Hemorrhage, vitreous
opacities — see Opacity, vitreous
prolapse — see Prolapse, vitreous
specified type NEC H43.89
voice R49.9
specified type NEC R49.8
volatile solvent use
due to drug abuse — see Abuse, drug, inhalant
due to drug dependence — see Dependence, drug, inhalant
voyeuristic F65.3
white blood cells D72.9
specified NEC D72.89
withdrawing, child or adolescent F40.10